A Phase I/II Study of RAD001 and Radiation Therapy in Patients With Brain Metastasis From Non-Small Cell Lung Cancer (NSCLC).

Trial Profile

A Phase I/II Study of RAD001 and Radiation Therapy in Patients With Brain Metastasis From Non-Small Cell Lung Cancer (NSCLC).

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2014

At a glance

  • Drugs Everolimus (Primary)
  • Indications Brain metastases; Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 Mar 2012 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.
    • 09 Aug 2011 Planned end date changed from 1 Jan 2014 to 1 Feb 2011 as reported by ClinicalTrials.gov.
    • 09 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top